In EC, SIX1 also plays an important role, and as a disease biomarker (Suen et al., 2016), its overexpression can promote the growth of tumor cells through ERK- and AKT-mediated pathways (Xin et al., 2016). This evidence concerns the gene AKT1 and neoplasm.